Table 1.
Baseline Characteristics | N=6 Median (25–75 IQR) |
---|---|
Age (y) | 56 (51–61) |
Male n (%) | 2 (33%) |
BMI | 24.5 (24.4–24.6) |
Laboratory and hemodynamic parameters | |
ALT (U/L) | 24 (16.75–33) |
Serum bilirubin (mg/dL) | 0.5 (0.1–0.7) |
Pathological conditions | |
Metastatic colorectal adenocarcinoma n (%) | 4 (67%) |
Focal nodular hyperplasia n (%) | 1 (17%) |
Metastatic ductal breast adenocarcinoma n (%) | 1 (17%) |
Background liver histology | |
Mild steatosis n (%) | 5 (83%) |
Fibrosis n (%) | 0 (0%) |
Abbreviations: BMI, body mass index.
All patients received chemotherapy prior to resection.
Research Ethics Committee reference 17/NE/0340- IRAS Project ID 222302